Hjalmar Nekarda
Overview
Explore the profile of Hjalmar Nekarda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
586
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lorenzen S, Panzram B, Rosenberg R, Nekarda H, Becker K, Schenk U, et al.
Ann Surg Oncol
. 2010 May;
17(10):2733-9.
PMID: 20490698
Background: Free peritoneal tumor cells (FPTCs) are an independent prognostic factor in patients undergoing curative resection for gastric carcinoma. Whether neoadjuvant chemotherapy (NAC) can eliminate FPTCs in the peritoneal lavage...
2.
Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, et al.
Ann Surg
. 2008 Dec;
248(6):968-78.
PMID: 19092341
Objective: We examined the prognostic impact of lymph node ratio (relation of tumor-infiltrated to resected lymph nodes) in comparison to the pN category and other prognostic factors in patients with...
3.
Doll D, Gertler R, Maak M, Friederichs J, Becker K, Geinitz H, et al.
World J Surg
. 2008 Nov;
33(2):340-7.
PMID: 19034566
Background: In colorectal surgery UICC/AJCC criteria require a yield of 12 or more locoregional lymph nodes for adequate staging. Neoadjuvant radiochemotherapy for rectal carcinoma reduces the number of lymph nodes...
4.
Rimkus C, Friederichs J, Boulesteix A, Theisen J, Mages J, Becker K, et al.
Clin Gastroenterol Hepatol
. 2008 Jan;
6(1):53-61.
PMID: 18166477
Background & Aims: Neoadjuvant chemoradiotherapy has become a standard treatment of locally advanced rectal carcinomas, even though the responsiveness varies from complete response to resistance. The aim of the study...
5.
Friederichs J, Gertler R, Rosenberg R, Dahm M, Nekarda H, Holzmann B, et al.
World J Surg
. 2007 Oct;
31(12):2329-34.
PMID: 17914651
Tumor cell dissemination appears to be an early event in tumor progression, and tumor cells can be detected in peripheral venous blood at the time of the operation. Although cytokeratin...
6.
Theisen J, Kauer W, Nekarda H, Schmid L, Stein H, Siewert J
J Gastrointest Surg
. 2006 Feb;
10(2):309-14.
PMID: 16455467
No abstract available.
7.
Lassmann S, Hennig M, Rosenberg R, Nahrig J, Schreglmann J, Krause F, et al.
Int J Colorectal Dis
. 2005 Sep;
21(3):238-47.
PMID: 16132996
Aim: Evaluation of thymidine phosphorylase (TP), dihydropyrimidine dehydrogenase (DPD), and thymidylate synthase (TS) mRNA levels in formalin-fixed, and paraffin-embedded tissues of patients with colorectal cancer and their prognostic and/or predictive...
8.
Michel K, Zeller F, Langer R, Nekarda H, Kruger D, Dover T, et al.
Gastroenterology
. 2005 May;
128(5):1317-26.
PMID: 15887114
Background & Aims: Serotonin (5-hydroxytryptamine [5-HT]) is a key signaling molecule in the gut. Recently, the neural 5-HT3 receptor received a lot of attention as a possible target in functional...
9.
Friederichs J, Rosenberg R, Mages J, Janssen K, Maeckl C, Nekarda H, et al.
Int J Colorectal Dis
. 2005 May;
20(5):391-402.
PMID: 15883783
Background And Aims: Colorectal cancer is one of the leading causes of cancer deaths in the Western world. A better understanding of the development and progression of colorectal carcinoma is...
10.
Friederichs J, Gertler R, Rosenberg R, Nahrig J, Fuhrer K, Holzmann B, et al.
World J Surg
. 2005 Mar;
29(4):422-8.
PMID: 15770378
Despite curative tumor resection, about 30%-50% of patients with locally advanced gastrointestinal (GI) carcinoma develop tumor recurrence which may be caused by pre- or intraoperative tumor cell dissemination. We examined...